Recognition of Pneumocystis carinii in foals with respiratory distress.

This research revolves around the study of five 3-month-old foals that showed signs of fever and respiratory disease, with a focus on the presence of a specific pneumonia causing organism, Pneumocystis carinii, in the affected lung sections. Effective diagnosis and treatment possibilities are explored.

Findings on Examination

• The foals displaying fever and respiratory issues had an autopsy performed, revealing lung abscesses and broad-ranging alveolar and interstitial pneumonia. These conditions were triggered by a bacterial infection from Rhodococcus equi and a significant presence of Pneumocystis carinii cysts in the affected areas of the lungs.

Radiographic Observations

• Radiography was done on all the 5 foals and it was found that three showed a distinct reticulonodular (miliary) pattern which could assist in ante-mortem diagnosis of P. carinii Pneumonia (PCP).

Differences in Blood Parameters

• Blood tests revealed that the foals infected with PCP had significantly greater leukocyte, or white blood cell, count than the control group with normal bacterial pneumonia. This increased leukocyte count signifies a higher level of body’s immune response, indicative of an advanced infection level.

Observations of Symptoms

• The foals infected with PCP displayed heightened tachypnoea, or rapid breathing, compared to the control group. Furthermore, 4 out of the 5 foals showed visible labored breathing, known as dyspnoea, before the eventual death.

Ante-Mortem Recognition of PCP

• The research points out that the diagnosis or recognition of PCP during the life of the foals may be accelerated by performing a bronchoalveolar lavage. This examination method involves inspection of a specimen of bronchoalveolar fluid for infectious agents.

Treatment for Foals with PCP

• For a successful treatment and recovery from PCP, the study suggests delivering adequate levels of potentiated sulphonamides, a class of antibiotics, as a potential solution. These drugs can halt the growth of Pneumocystis carinii, thus potentially curing the foals of PCP.